Consistent with its potential immune inhibitory effect revealed by CRISPRa screening, IL10RB-DT showed higher expression levels in tumor tissues including melanoma, pancreatic adenocarcinoma, and kidney carcinoma (fig. The gene discussed is IL10RB; the disease is renal carcinoma.